Compare Cadila Healthcare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALKEM LABORATORIES - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALKEM LABORATORIES CADILA HEALTHCARE/
ALKEM LABORATORIES
 
P/E (TTM) x 30.2 - - View Chart
P/BV x 3.6 8.0 45.0% View Chart
Dividend Yield % 1.0 0.5 177.0%  

Financials

 CADILA HEALTHCARE   ALKEM LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
ALKEM LABORATORIES
Mar-16
CADILA HEALTHCARE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4321,589 27.2%   
Low Rs3061,232 24.9%   
Sales per share (Unadj.) Rs128.6417.5 30.8%  
Earnings per share (Unadj.) Rs18.556.3 32.9%  
Cash flow per share (Unadj.) Rs24.464.7 37.7%  
Dividends per share (Unadj.) Rs3.5012.70 27.6%  
Dividend yield (eoy) %0.90.9 105.2%  
Book value per share (Unadj.) Rs101.5292.9 34.6%  
Shares outstanding (eoy) m1,023.74119.57 856.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.93.4 85.0%   
Avg P/E ratio x19.925.1 79.5%  
P/CF ratio (eoy) x15.121.8 69.5%  
Price / Book Value ratio x3.64.8 75.6%  
Dividend payout %18.922.6 83.7%   
Avg Mkt Cap Rs m378,170168,653 224.2%   
No. of employees `00012.4NA-   
Total wages/salary Rs m21,2419,171 231.6%   
Avg. sales/employee Rs Th10,585.0NM-  
Avg. wages/employee Rs Th1,707.8NM-  
Avg. net profit/employee Rs Th1,526.5NM-  
INCOME DATA
Net Sales Rs m131,65649,915 263.8%  
Other income Rs m2,0111,645 122.2%   
Total revenues Rs m133,66751,561 259.2%   
Gross profit Rs m29,7318,482 350.5%  
Depreciation Rs m5,9861,006 595.1%   
Interest Rs m1,935671 288.5%   
Profit before tax Rs m23,8218,451 281.9%   
Minority Interest Rs m469-114 -412.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,3031,606 330.2%   
Profit after tax Rs m18,9876,731 282.1%  
Gross profit margin %22.617.0 132.9%  
Effective tax rate %22.319.0 117.1%   
Net profit margin %14.413.5 106.9%  
BALANCE SHEET DATA
Current assets Rs m84,98127,062 314.0%   
Current liabilities Rs m73,42515,324 479.2%   
Net working cap to sales %8.823.5 37.3%  
Current ratio x1.21.8 65.5%  
Inventory Days Days7567 112.1%  
Debtors Days Days11041 265.3%  
Net fixed assets Rs m133,49312,610 1,058.7%   
Share capital Rs m1,024239 428.3%   
"Free" reserves Rs m102,83934,490 298.2%   
Net worth Rs m103,86335,027 296.5%   
Long term debt Rs m39,4971,212 3,259.9%   
Total assets Rs m234,83154,387 431.8%  
Interest coverage x13.313.6 97.9%   
Debt to equity ratio x0.40 1,099.4%  
Sales to assets ratio x0.60.9 61.1%   
Return on assets %8.913.6 65.5%  
Return on equity %18.319.2 95.1%  
Return on capital %18.324.9 73.6%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m48,4046,563 737.5%   
Fx outflow Rs m11,5933,012 384.9%   
Net fx Rs m36,8113,552 1,036.5%   
CASH FLOW
From Operations Rs m28,8237,259 397.1%  
From Investments Rs m-57,3871,864 -3,078.4%  
From Financial Activity Rs m18,846-9,273 -203.2%  
Net Cashflow Rs m-7,105-150 4,736.7%  

Share Holding

Indian Promoters % 74.8 66.9 111.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 33.1 25.1%  
FIIs % 5.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 0.0 -  
Shareholders   44,069 68,381 64.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 3, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS